A systematic review of systematic reviews and pooled meta-analysis on pharmacological interventions to improve cancer-related fatigue
Silvia Belloni(IRCCS Humanitas Research Hospital), Rosario Caruso(University of Milan), Rita De Sanctis(Humanitas University), Cristina Arrigoni(University of Pavia), Federica Dellafiore(IRCCS Policlinico San Donato), Marco Alfredo Arcidiacono(University of Parma)
Cited by 20
Related Papers
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
‘Vaccine hesitancy’ among university students in Italy during the COVID-19 pandemic
|European Journal of Epidemiology|2020|446
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
|The Lancet Neurology|2021|260
Functional changes in Duchenne muscular dystrophy
|Neurology|2011|178
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy
|European Journal of Nuclear Medicine and Molecular Imaging|2019|150